Selected research
Industry Research
X-protein Industry Research Report 2026
Market perspective
The global X-protein market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for X-protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for X-protein is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for X-protein is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of X-protein include Albumedix A/S, CSL Behring LLC, GRIFOLS INTERNATIONAL, S.A., HiMedia Laboratories, InVitria, Kedrion S.p.A, Medxbio Pte Ltd, Mitsubishi Tanabe Pharma Corporation and Octapharma AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global X-protein market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
X-protein Market by Company
Albumedix A/S
CSL Behring LLC
GRIFOLS INTERNATIONAL, S.A.
HiMedia Laboratories
InVitria
Kedrion S.p.A
Medxbio Pte Ltd
Mitsubishi Tanabe Pharma Corporation
Octapharma AG
Shire Plc. (Baxalta Inc.)
Sigma-Aldrich Co. LLC.
Thermo Fisher Scientific Inc
X-protein Segment by Type
Bovine Serum Albumin
Human Serum Albumin
Recombinant Albumin
X-protein Segment by Application
Drug Formulation and Vaccines
Blood Volumizer
Life Sciences
Others
X-protein Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global X-protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of X-protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of X-protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of X-protein manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of X-protein by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of X-protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bovine Serum Albumin
- Human Serum Albumin
- Recombinant Albumin
Applications
- Drug Formulation and Vaccines
- Blood Volumizer
- Life Sciences
- Others
Companies covered
- Albumedix A/S
- CSL Behring LLC
- GRIFOLS INTERNATIONAL, S.A.
- HiMedia Laboratories
- InVitria
- Kedrion S.p.A
- Medxbio Pte Ltd
- Mitsubishi Tanabe Pharma Corporation
- Octapharma AG
- Shire Plc. (Baxalta Inc.)
- Sigma-Aldrich Co. LLC.
- Thermo Fisher Scientific Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global X-protein Market Size (2021-2032)
- 2.2.2 Global X-protein Sales (2021-2032)
- 2.2.3 Global X-protein Market Average Price (2021-2032)
- 2.3 X-protein by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Bovine Serum Albumin
- 2.3.3 Human Serum Albumin
- 2.3.4 Recombinant Albumin
- 2.4 X-protein by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Drug Formulation and Vaccines
- 2.4.3 Blood Volumizer
- 2.4.4 Life Sciences
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global X-protein Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global X-protein Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global X-protein Revenue of Manufacturers (2021-2026)
- 3.4 Global X-protein Average Price by Manufacturers (2021-2026)
- 3.5 Global X-protein Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of X-protein, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of X-protein, Product Type & Application
- 3.8 Global Manufacturers of X-protein, Established Date
- 3.9 Global X-protein Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Albumedix A/S
- 4.1.1 Albumedix A/S Company Information
- 4.1.2 Albumedix A/S Business Overview
- 4.1.3 Albumedix A/S X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Albumedix A/S X-protein Product Portfolio
- 4.1.5 Albumedix A/S Recent Developments
- 4.2 CSL Behring LLC
- 4.2.1 CSL Behring LLC Company Information
- 4.2.2 CSL Behring LLC Business Overview
- 4.2.3 CSL Behring LLC X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CSL Behring LLC X-protein Product Portfolio
- 4.2.5 CSL Behring LLC Recent Developments
- 4.3 GRIFOLS INTERNATIONAL, S.A.
- 4.3.1 GRIFOLS INTERNATIONAL, S.A. Company Information
- 4.3.2 GRIFOLS INTERNATIONAL, S.A. Business Overview
- 4.3.3 GRIFOLS INTERNATIONAL, S.A. X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GRIFOLS INTERNATIONAL, S.A. X-protein Product Portfolio
- 4.3.5 GRIFOLS INTERNATIONAL, S.A. Recent Developments
- 4.4 HiMedia Laboratories
- 4.4.1 HiMedia Laboratories Company Information
- 4.4.2 HiMedia Laboratories Business Overview
- 4.4.3 HiMedia Laboratories X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 HiMedia Laboratories X-protein Product Portfolio
- 4.4.5 HiMedia Laboratories Recent Developments
- 4.5 InVitria
- 4.5.1 InVitria Company Information
- 4.5.2 InVitria Business Overview
- 4.5.3 InVitria X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 InVitria X-protein Product Portfolio
- 4.5.5 InVitria Recent Developments
- 4.6 Kedrion S.p.A
- 4.6.1 Kedrion S.p.A Company Information
- 4.6.2 Kedrion S.p.A Business Overview
- 4.6.3 Kedrion S.p.A X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Kedrion S.p.A X-protein Product Portfolio
- 4.6.5 Kedrion S.p.A Recent Developments
- 4.7 Medxbio Pte Ltd
- 4.7.1 Medxbio Pte Ltd Company Information
- 4.7.2 Medxbio Pte Ltd Business Overview
- 4.7.3 Medxbio Pte Ltd X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Medxbio Pte Ltd X-protein Product Portfolio
- 4.7.5 Medxbio Pte Ltd Recent Developments
- 4.8 Mitsubishi Tanabe Pharma Corporation
- 4.8.1 Mitsubishi Tanabe Pharma Corporation Company Information
- 4.8.2 Mitsubishi Tanabe Pharma Corporation Business Overview
- 4.8.3 Mitsubishi Tanabe Pharma Corporation X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mitsubishi Tanabe Pharma Corporation X-protein Product Portfolio
- 4.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
- 4.9 Octapharma AG
- 4.9.1 Octapharma AG Company Information
- 4.9.2 Octapharma AG Business Overview
- 4.9.3 Octapharma AG X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Octapharma AG X-protein Product Portfolio
- 4.9.5 Octapharma AG Recent Developments
- 4.10 Shire Plc. (Baxalta Inc.)
- 4.10.1 Shire Plc. (Baxalta Inc.) Company Information
- 4.10.2 Shire Plc. (Baxalta Inc.) Business Overview
- 4.10.3 Shire Plc. (Baxalta Inc.) X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shire Plc. (Baxalta Inc.) X-protein Product Portfolio
- 4.10.5 Shire Plc. (Baxalta Inc.) Recent Developments
- 4.11 Sigma-Aldrich Co. LLC.
- 4.11.1 Sigma-Aldrich Co. LLC. Company Information
- 4.11.2 Sigma-Aldrich Co. LLC. Business Overview
- 4.11.3 Sigma-Aldrich Co. LLC. X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sigma-Aldrich Co. LLC. X-protein Product Portfolio
- 4.11.5 Sigma-Aldrich Co. LLC. Recent Developments
- 4.12 Thermo Fisher Scientific Inc
- 4.12.1 Thermo Fisher Scientific Inc Company Information
- 4.12.2 Thermo Fisher Scientific Inc Business Overview
- 4.12.3 Thermo Fisher Scientific Inc X-protein Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Thermo Fisher Scientific Inc X-protein Product Portfolio
- 4.12.5 Thermo Fisher Scientific Inc Recent Developments
5 Global X-protein Market Scenario by Region
- 5.1 Global X-protein Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global X-protein Sales by Region: 2021-2032
- 5.2.1 Global X-protein Sales by Region: 2021-2026
- 5.2.2 Global X-protein Sales by Region: 2027-2032
- 5.3 Global X-protein Revenue by Region: 2021-2032
- 5.3.1 Global X-protein Revenue by Region: 2021-2026
- 5.3.2 Global X-protein Revenue by Region: 2027-2032
- 5.4 North America X-protein Market Facts & Figures by Country
- 5.4.1 North America X-protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America X-protein Sales by Country (2021-2032)
- 5.4.3 North America X-protein Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe X-protein Market Facts & Figures by Country
- 5.5.1 Europe X-protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe X-protein Sales by Country (2021-2032)
- 5.5.3 Europe X-protein Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific X-protein Market Facts & Figures by Country
- 5.6.1 Asia Pacific X-protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific X-protein Sales by Country (2021-2032)
- 5.6.3 Asia Pacific X-protein Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America X-protein Market Facts & Figures by Country
- 5.7.1 South America X-protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America X-protein Sales by Country (2021-2032)
- 5.7.3 South America X-protein Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa X-protein Market Facts & Figures by Country
- 5.8.1 Middle East and Africa X-protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa X-protein Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa X-protein Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global X-protein Sales by Type (2021-2032)
- 6.1.1 Global X-protein Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global X-protein Sales Market Share by Type (2021-2032)
- 6.2 Global X-protein Revenue by Type (2021-2032)
- 6.2.1 Global X-protein Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global X-protein Revenue Market Share by Type (2021-2032)
- 6.3 Global X-protein Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global X-protein Sales by Application (2021-2032)
- 7.1.1 Global X-protein Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global X-protein Sales Market Share by Application (2021-2032)
- 7.2 Global X-protein Revenue by Application (2021-2032)
- 7.2.1 Global X-protein Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global X-protein Revenue Market Share by Application (2021-2032)
- 7.3 Global X-protein Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 X-protein Value Chain Analysis
- 8.1.1 X-protein Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 X-protein Production Mode & Process
- 8.2 X-protein Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 X-protein Distributors
- 8.2.3 X-protein Customers
9 Global X-protein Analyzing Market Dynamics
- 9.1 X-protein Industry Trends
- 9.2 X-protein Industry Drivers
- 9.3 X-protein Industry Opportunities and Challenges
- 9.4 X-protein Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst